IPA-3
货号：
14759-5mg 基本售价：
630.0 元 规格：
5 mg
产品信息
概述| 货号 | 14759-5mg |
| 描述 | p21-activated kinase 1 (PAK1) is a member of a family non-receptor serine/threonine kinases that are vital to normal cell function. Binding of various upstream partners to PAK1 results in release of an autoinhibitory domain that blocks activity of the kinase domain.1 PAK1 expression and activity is upregulated in several human cancers and is a potential therapeutic target for cancer intervention.1 IPA-3 is a cell-permeable allosteric inhibitor of PAK1 that is non-competitive with respect to ATP binding (IC50 = 2.5 µM).2 It does not, however, inhibit the activity of PAK1 that has been pre-activated with Cdc42. IPA-3 binds covalently to the PAK1 regulatory domain (apparent Kd = 1.9 uM) and prevents binding to the upstream activator Cdc42.3 |
性能| 供应商 | Cayman |
| 应用文献 |
1.Kumar, R.,Gururaj, A.E. and Barnes, C.J. p21-activated kinases in cancer. Nat.Rev.Cancer. 6(6), 459-471 (2006).
2.Deacon, S.W.,Beeser, A.,Fukui, J.A., et al. An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase. Chemistry & Biology 15(4), 322-331 (2008).
3.Viaud, J. and Peterson, J.R. An allosteric kinase inhibitor binds the p21-activated kinase autoregulatory domain covalently. Molecular Cancer Therapeutics 8(9), 2559-2565 (2009).
|
| 运输条件 | Room temperature in continental US; may vary elsewhere |
| 存放说明 | -20 |
| 纯度 | ≥95% |
| 计算分子量 | 350.5 |
| 分子式 | C20H14O2S2 |
| CAS号 | 42521-82-4 |
| 稳定性 | ≥ 2 years |
声明| 本官网所有报价均为常温或者蓝冰运输价格，如有产品需要干冰运输，需另外加收干冰运输费。 |
